Cassaday & Co Wealth Management LLC lifted its stake in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) by 1.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,834 shares of the exchange traded fund’s stock after acquiring an additional 521 shares […]
Could Biotech ETFs Be Due For More Upside? etftrends.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etftrends.com Daily Mail and Mail on Sunday newspapers.
Biotech ETFs Benefit From Moderna Dual Booster Shot News etftrends.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etftrends.com Daily Mail and Mail on Sunday newspapers.